Fenbufen

DB08981

small molecule approved

Deskripsi

Fenbufen is a non-steroidal anti-inflammatory drug used primarily to treat inflammation in osteoarthritis, ankylosing spondylitis, and tendinitis. It can also be used to relieve backaches, sprains, and fractures. Fenbufen is available as a capsule or tablet sold with the brand names Cepal, Cinopal, Cybufen, Lederfen, and Reugast. Fenbufen acts by preventing cyclooxygenase from producing prostaglandins which can cause inflammation.

Struktur Molekul 2D

Berat 254.2806
Wujud solid

Peta Jejaring Molekuler
Legenda: Obat • Target • Gen • Enzim • (Panah → menunjukkan arah efek / relasi) • Transporter • Carrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

1386 Data
Amlodipine Fenbufen may decrease the antihypertensive activities of Amlodipine.
Phentermine The risk or severity of hypertension can be increased when Phentermine is combined with Fenbufen.
Midodrine The risk or severity of hypertension can be increased when Midodrine is combined with Fenbufen.
Eletriptan The risk or severity of hypertension can be increased when Eletriptan is combined with Fenbufen.
Isoetharine The risk or severity of hypertension can be increased when Isoetharine is combined with Fenbufen.
Ziprasidone The risk or severity of hypertension can be increased when Ziprasidone is combined with Fenbufen.
Methysergide The risk or severity of hypertension can be increased when Methysergide is combined with Fenbufen.
Cabergoline The risk or severity of hypertension can be increased when Cabergoline is combined with Fenbufen.
Zolmitriptan The risk or severity of hypertension can be increased when Zolmitriptan is combined with Fenbufen.
Dihydroergotamine The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Fenbufen.
Methylergometrine The risk or severity of hypertension can be increased when Methylergometrine is combined with Fenbufen.
Norepinephrine The risk or severity of hypertension can be increased when Norepinephrine is combined with Fenbufen.
Mirtazapine The risk or severity of hypertension can be increased when Mirtazapine is combined with Fenbufen.
Phenylephrine The risk or severity of hypertension can be increased when Phenylephrine is combined with Fenbufen.
Phenylpropanolamine The risk or severity of hypertension can be increased when Phenylpropanolamine is combined with Fenbufen.
Promazine The risk or severity of hypertension can be increased when Promazine is combined with Fenbufen.
Droperidol The risk or severity of hypertension can be increased when Droperidol is combined with Fenbufen.
Doxapram The risk or severity of hypertension can be increased when Doxapram is combined with Fenbufen.
Atropine The risk or severity of hypertension can be increased when Atropine is combined with Fenbufen.
Lisuride The risk or severity of hypertension can be increased when Lisuride is combined with Fenbufen.
Linezolid The risk or severity of hypertension can be increased when Linezolid is combined with Fenbufen.
Metaraminol The risk or severity of hypertension can be increased when Metaraminol is combined with Fenbufen.
Furazolidone The risk or severity of hypertension can be increased when Furazolidone is combined with Fenbufen.
Epinephrine The risk or severity of hypertension can be increased when Epinephrine is combined with Fenbufen.
Thioridazine The risk or severity of hypertension can be increased when Thioridazine is combined with Fenbufen.
Ergotamine The risk or severity of hypertension can be increased when Ergotamine is combined with Fenbufen.
Nicergoline The risk or severity of hypertension can be increased when Nicergoline is combined with Fenbufen.
Sufentanil The risk or severity of hypertension can be increased when Sufentanil is combined with Fenbufen.
Methoxamine The risk or severity of hypertension can be increased when Methoxamine is combined with Fenbufen.
Risperidone The risk or severity of hypertension can be increased when Risperidone is combined with Fenbufen.
Tranylcypromine The risk or severity of hypertension can be increased when Tranylcypromine is combined with Fenbufen.
Isoflurane The risk or severity of hypertension can be increased when Isoflurane is combined with Fenbufen.
Propiomazine The risk or severity of hypertension can be increased when Propiomazine is combined with Fenbufen.
Alfentanil The risk or severity of hypertension can be increased when Alfentanil is combined with Fenbufen.
Minaprine The risk or severity of hypertension can be increased when Minaprine is combined with Fenbufen.
Orciprenaline The risk or severity of hypertension can be increased when Orciprenaline is combined with Fenbufen.
Propofol The risk or severity of hypertension can be increased when Propofol is combined with Fenbufen.
Phenmetrazine The risk or severity of hypertension can be increased when Phenmetrazine is combined with Fenbufen.
Trifluoperazine The risk or severity of hypertension can be increased when Trifluoperazine is combined with Fenbufen.
Pseudoephedrine The risk or severity of hypertension can be increased when Pseudoephedrine is combined with Fenbufen.
Benzphetamine The risk or severity of hypertension can be increased when Benzphetamine is combined with Fenbufen.
Ritodrine The risk or severity of hypertension can be increased when Ritodrine is combined with Fenbufen.
Flupentixol The risk or severity of hypertension can be increased when Flupentixol is combined with Fenbufen.
Remifentanil The risk or severity of hypertension can be increased when Remifentanil is combined with Fenbufen.
Bitolterol The risk or severity of hypertension can be increased when Bitolterol is combined with Fenbufen.
Oxymetazoline The risk or severity of hypertension can be increased when Oxymetazoline is combined with Fenbufen.
Diethylpropion The risk or severity of hypertension can be increased when Diethylpropion is combined with Fenbufen.
Salmeterol The risk or severity of hypertension can be increased when Salmeterol is combined with Fenbufen.
Naratriptan The risk or severity of hypertension can be increased when Naratriptan is combined with Fenbufen.
Formoterol The risk or severity of hypertension can be increased when Formoterol is combined with Fenbufen.
Frovatriptan The risk or severity of hypertension can be increased when Frovatriptan is combined with Fenbufen.
Methoxyflurane The risk or severity of hypertension can be increased when Methoxyflurane is combined with Fenbufen.
Selegiline The risk or severity of hypertension can be increased when Selegiline is combined with Fenbufen.
Ergoloid mesylate The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Fenbufen.
Isoprenaline The risk or severity of hypertension can be increased when Isoprenaline is combined with Fenbufen.
Arbutamine The risk or severity of hypertension can be increased when Arbutamine is combined with Fenbufen.
Dutasteride The risk or severity of hypertension can be increased when Dutasteride is combined with Fenbufen.
Halothane The risk or severity of hypertension can be increased when Halothane is combined with Fenbufen.
Moclobemide The risk or severity of hypertension can be increased when Moclobemide is combined with Fenbufen.
Pergolide The risk or severity of hypertension can be increased when Pergolide is combined with Fenbufen.
Desflurane The risk or severity of hypertension can be increased when Desflurane is combined with Fenbufen.
Bromocriptine The risk or severity of hypertension can be increased when Bromocriptine is combined with Fenbufen.
Finasteride The risk or severity of hypertension can be increased when Finasteride is combined with Fenbufen.
Aripiprazole The risk or severity of hypertension can be increased when Aripiprazole is combined with Fenbufen.
Isocarboxazid The risk or severity of hypertension can be increased when Isocarboxazid is combined with Fenbufen.
Ergometrine The risk or severity of hypertension can be increased when Ergometrine is combined with Fenbufen.
Lisdexamfetamine The risk or severity of hypertension can be increased when Lisdexamfetamine is combined with Fenbufen.
Fenoterol The risk or severity of hypertension can be increased when Fenoterol is combined with Fenbufen.
Pirbuterol The risk or severity of hypertension can be increased when Pirbuterol is combined with Fenbufen.
Ephedra sinica root The risk or severity of hypertension can be increased when Ephedra sinica root is combined with Fenbufen.
Ephedrine The risk or severity of hypertension can be increased when Ephedrine is combined with Fenbufen.
Mephentermine The risk or severity of hypertension can be increased when Mephentermine is combined with Fenbufen.
Procaterol The risk or severity of hypertension can be increased when Procaterol is combined with Fenbufen.
Yohimbine The risk or severity of hypertension can be increased when Yohimbine is combined with Fenbufen.
Methotrimeprazine The risk or severity of hypertension can be increased when Methotrimeprazine is combined with Fenbufen.
Clenbuterol The risk or severity of hypertension can be increased when Clenbuterol is combined with Fenbufen.
Bambuterol The risk or severity of hypertension can be increased when Bambuterol is combined with Fenbufen.
MMDA The risk or severity of hypertension can be increased when MMDA is combined with Fenbufen.
Midomafetamine The risk or severity of hypertension can be increased when Midomafetamine is combined with Fenbufen.
2,5-Dimethoxy-4-ethylamphetamine The risk or severity of hypertension can be increased when 2,5-Dimethoxy-4-ethylamphetamine is combined with Fenbufen.
4-Methoxyamphetamine The risk or severity of hypertension can be increased when 4-Methoxyamphetamine is combined with Fenbufen.
4-Bromo-2,5-dimethoxyamphetamine The risk or severity of hypertension can be increased when 4-Bromo-2,5-dimethoxyamphetamine is combined with Fenbufen.
Tenamfetamine The risk or severity of hypertension can be increased when Tenamfetamine is combined with Fenbufen.
Chlorphentermine The risk or severity of hypertension can be increased when Chlorphentermine is combined with Fenbufen.
Dextroamphetamine The risk or severity of hypertension can be increased when Dextroamphetamine is combined with Fenbufen.
Phendimetrazine The risk or severity of hypertension can be increased when Phendimetrazine is combined with Fenbufen.
Solifenacin The risk or severity of hypertension can be increased when Solifenacin is combined with Fenbufen.
Periciazine The risk or severity of hypertension can be increased when Periciazine is combined with Fenbufen.
Acepromazine The risk or severity of hypertension can be increased when Acepromazine is combined with Fenbufen.
Thioproperazine The risk or severity of hypertension can be increased when Thioproperazine is combined with Fenbufen.
Zuclopenthixol The risk or severity of hypertension can be increased when Zuclopenthixol is combined with Fenbufen.
Epicaptopril The risk or severity of hypertension can be increased when Epicaptopril is combined with Fenbufen.
Clorgiline The risk or severity of hypertension can be increased when Clorgiline is combined with Fenbufen.
1-benzylimidazole The risk or severity of hypertension can be increased when 1-benzylimidazole is combined with Fenbufen.
Iproniazid The risk or severity of hypertension can be increased when Iproniazid is combined with Fenbufen.
Nialamide The risk or severity of hypertension can be increased when Nialamide is combined with Fenbufen.
Lysergic acid diethylamide The risk or severity of hypertension can be increased when Lysergic acid diethylamide is combined with Fenbufen.
Dronedarone The risk or severity of hypertension can be increased when Dronedarone is combined with Fenbufen.
Flibanserin The risk or severity of hypertension can be increased when Flibanserin is combined with Fenbufen.
Iloperidone The risk or severity of hypertension can be increased when Iloperidone is combined with Fenbufen.

Target Protein

Prostaglandin G/H synthase 2 PTGS2
Prostaglandin G/H synthase 1 PTGS1

Referensi & Sumber

Synthesis reference: U.S. Patent 3,784,701.

Contoh Produk & Brand

Produk: 0 • International brands: 0
Belum ada data produk/brand untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field produk/brand.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul